Chinese Company's Subsidiary Obtains Order for Tobacco Testing Equipment

Aug.31.2022

Chinese company, Zhongke Information, announces its subsidiary, Ruituo Technology, has secured an order from Inno-IT to sell products to South Korea again.

On August 30th, a reporter from China Securities Journal learned from Chengdu Information Technology Co., Ltd. (referred to as "CIT") that its wholly-owned subsidiary, Retek Technology, has obtained an order from Inno-IT company, and the products will once again be sold to South Korea.

According to reports, as both domestic and international tobacco markets have increasingly strict requirements for the quality of cigarette production, the technical demands for tobacco testing instruments have continued to rise. However, the current market for tobacco testing instruments is characterized by low accuracy, limited availability, and high prices. Ruituo Technology is a well-known domestic provider of tobacco physical testing equipment. Their tobacco testing instruments are known for their high accuracy, superior quality, and wide range of varieties. Some of the indicator parameters have even surpassed similar imported instruments, giving Ruituo Technology a relatively high market share in China. Furthermore, their products have been exported to countries such as Russia, Indonesia, North Korea, Cambodia, and South Korea.

RuiTuo Technology's smart physical detection solution for the tobacco industry, unveiled at the Bulgaria International Tobacco Exhibition on May 18, 2022, has garnered considerable attention. This collaboration with Inno-IT marks RuiTuo Technology's second order from South Korea since 2006.

China Science Information (中科信息) stated that Rutotech (瑞拓科技) aims to become a "world-class manufacturer of intelligent tobacco industry testing equipment". The company plans to increase research and development efforts as well as investment in the domestic market for tobacco physical testing equipment, while actively expanding into European and Asia-Pacific markets. Rutotech aims to grow and strengthen its brand in the industry.

This article contains excerpts or reprints from third-party sources. The copyright belongs to the original media and author. If there is any infringement, please contact us for removal. Any organization or individual wishing to reproduce it should contact the author directly and refrain from direct reproduction.

#PMI #Drug testing

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Thailand’s health minister rejects vaping as a smoking cessation alternative

Thailand’s Public Health Minister Phatthana Phromphat has reaffirmed that the government does not support cigarettes or e-cigarettes in any form and opposes the use of e-cigarettes as a substitute for smoking cessation.

Dec.17 by 2FIRSTS.ai

Japan Tobacco Expands Ploom Aura EVO Menthol Line With Two New Products and One Upgraded Blend

Japan Tobacco Inc. (JT) has added two new EVO sticks, Evo Black Menthol and Evo Fresh Mint, to its Ploom Aura lineup and reformulated Evo Cold Menthol, creating a menthol range with three distinct levels of cooling intensity and flavor profile.

Dec.01 by 2FIRSTS.ai

Scandinavian Tobacco Group Reports Q3 2025 Results and Narrows Full-Year Guidance

Scandinavian Tobacco Group (STG) reported net sales of DKK 2.4 billion for Q3 2025, in line with last year. EBITDA before special items reached DKK 519 million with a 22.0% margin. Handmade Cigars and Next Generation Products saw organic growth, while Machine-Rolled Cigars and Smoking Tobacco declined. The company narrowed its full-year guidance.

Nov.12 by 2FIRSTS.ai

UK Experts Raise Concerns Over High-Dose Nicotine Pouches Amid Rising Sales

According to The Guardian, health experts in the UK are warning about the potential health effects of high-dose nicotine pouches as their sales continue to rise. Recent studies show teenagers reporting nicotine rushes, sickness and fainting, while researchers say packaging and marketing increasingly appeal to younger age groups. Although viewed as less harmful than cigarettes, experts remain concerned about their use among non-smokers, especially adolescents.